Silvia La Monica - Concepedia

Author

Silvia La Monica

University of Parma ORCID

Also Known As

Arturo Ciccullo, S La Monica, S. La Monica, S. Monica, Silvia La Monica, Silvia Monica, Valentina Iodice

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Parma Istituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro Istituti Ospitalieri di Cremona IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola University of Bologna

About

Silvia La Monica is an author at University of Parma specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	949
2	Cell Biology	15	16	766
3	Health Sciences	2	2	79
4	Natural Sciences	1	1	46
5	Biochemistry	1	1	46

Silvia La Monica

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Human myeloma cells stimulate the receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease Nicola Giuliani, Simona Colla, Roberto Sala, Blood	2002	265
Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells Mara Bonelli, Graziana Digiacomo, Claudia Fumarola, Neoplasia	2017	102
The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells Daniele Cretella, Andrea Ravelli, Claudia Fumarola, Journal of Experimental & Clinical Cancer Research	2018	99
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines Silvia La Monica, Daniele Cretella, Mara Bonelli, Journal of Experimental & Clinical Cancer Research	2017	89
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones Andrea Cavazzoni, Mara Bonelli, Claudia Fumarola, Cancer Letters Breast OncologyMedicineBreast CancerAnti-cancer AgentTumor Suppressor	2012	88
Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells Daniele Cretella, Claudia Fumarola, Mara Bonelli, Scientific Reports	2019	86
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines Silvia La Monica, Maricla Galetti, Roberta Alfieri, Biochemical Pharmacology Gefitinib SensitivityMedicineImmune Checkpoint InhibitorCancer BiologyCancer Treatment	2009	82
Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis Claudia Fumarola, Silvia La Monica, Roberta Alfieri, Cell Death and Differentiation Signal TransductionSignaling PathwayCell RegulationReceptor Tyrosine KinaseApoptosis	2005	81
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR- Activating Mutation Silvia La Monica, Denise Madeddu, Marcello Tiseo, Journal of Thoracic Oncology Signal TransductionSignaling PathwayReceptor Tyrosine KinasePemetrexed PreventsSystems Biology	2016	78
Amino acid signaling through the mammalian target of rapamycin (mTOR) pathway: Role of glutamine and of cell shrinkage Claudia Fumarola, Silvia La Monica, Guido Guidotti Journal of Cellular Physiology	2004	72

Page 1